JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 10.76% |
| 3 | Healthcare | 10.54% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 6.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
PUT
Dave & Buster's
PLAY
$354M
| $772K | ﹤0.01% |
+57,900
| New | +$772K |
|
|
MTEM
3502
DELISTED
Molecular Templates, Inc.
MTEM
| $769K | ﹤0.01% |
3,717
-3,548
| -49% | -$824K |
|
|
GHL
3503
DELISTED
Greenhill & Co., Inc.
GHL
| $766K | ﹤0.01% |
76,600
+71,508
| +1,404% | +$706K |
|
|
DCH
3504
CALL
Dauch Corp
DCH
$1.6B
| $760K | ﹤0.01% |
100,000
| – | – |
|
|
TC
3505
TuanChe
TC
$57.3M
| $760K | ﹤0.01% |
391
+33
| +9% | +$59.6K |
|
3506
CALL
TripAdvisor
TRIP
$1.26B
| $760K | ﹤0.01% |
40,000
| – | – |
|
|
3507
PUT
TripAdvisor
TRIP
$1.26B
| $760K | ﹤0.01% |
40,000
| – | – |
|
|
GPMT
3508
Granite Point Mortgage Trust
GPMT
$57.4M
| $757K | ﹤0.01% |
105,365
+80,110
| +317% | +$435K |
|
3509
Astrana Health
ASTH
$2.02B
| $756K | ﹤0.01% |
45,856
-3,983
| -8% | -$62.7K |
|
3510
Oppenheimer Holdings
OPY
$1.25B
| $755K | ﹤0.01% |
34,624
-34,707
| -50% | -$702K |
|
|
DCPH
3511
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $754K | ﹤0.01% |
12,630
+5,841
| +86% | +$312K |
|
3512
NextCure
NXTC
$37.6M
| $753K | ﹤0.01% |
2,929
+2,543
| +659% | +$968K |
|
3513
Encore Capital Group
ECPG
$2.2B
| $749K | ﹤0.01% |
21,912
-142,231
| -87% | -$4.24M |
|
3514
CALL
Voyager Therapeutics
VYGR
$201M
| $748K | ﹤0.01% |
+59,300
| New | +$690K |
|
3515
CarGurus
CARG
$3.33B
| $745K | ﹤0.01% |
29,405
-376,465
| -93% | -$8.77M |
|
|
MFA
3516
MFA Financial
MFA
$926M
| $745K | ﹤0.01% |
74,811
-38,950
| -34% | -$301K |
|
3517
PUT
Target
TGT
$70.2B
| $744K | ﹤0.01% |
6,200
-193,100
| -97% | -$22M |
|
|
INOV
3518
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $744K | ﹤0.01% |
38,604
-72,396
| -65% | -$1.28M |
|
3519
Movado Group
MOV
$803M
| $742K | ﹤0.01% |
68,540
-86,723
| -56% | -$936K |
|
3520
Rigel Pharmaceuticals
RIGL
$795M
| $740K | ﹤0.01% |
40,414
-23,025
| -36% | -$414K |
|
3521
Shore Bancshares
SHBI
$800M
| $739K | ﹤0.01% |
66,643
-22,401
| -25% | -$219K |
|
3522
Schwab International Equity ETF
SCHF
$69.4B
| $737K | ﹤0.01% |
49,516
-6,588
| -12% | -$92.6K |
|
|
UBX
3523
DELISTED
Unity Biotechnology
UBX
| $735K | ﹤0.01% |
8,470
+7,557
| +828% | +$560K |
|
3524
CALL
Alector
ALEC
$219M
| $733K | ﹤0.01% |
30,000
-15,000
| -33% | -$414K |
|
3525
Kodiak Sciences
KOD
$2.59B
| $730K | ﹤0.01% |
13,496
+4,422
| +49% | +$249K |
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,341 reduced and 399 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 399 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.